Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Cleveland Diagnostics, Inc.
Cleveland Diagnostics Announces Landmark Longitudinal Study Published in Urology
April 23, 2025
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics’ Prostate Cancer Awareness Campaign ‘A PSA on PSA’ Returns This September
August 27, 2024
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics Adds Dara Grantham Wright to Board of Directors
July 23, 2024
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform
January 17, 2024
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics Announces Prostate Cancer Awareness Month Campaign: ‘A PSA on PSA’
August 30, 2023
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics Opens New Facility Amid Growing Demand for IsoPSA® Test
June 28, 2023
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics Announces Agreement with Quest Diagnostics to Expand Patient Access to IsoPSA® Prostate Cancer Testing
February 13, 2023
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics Announces the Publication of Two Major IsoPSA® Studies
October 31, 2022
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics Announces Favorable Medicare Local Coverage Determination and Assignment of a CPT-PLA Code for IsoPSA®
October 13, 2022
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics Announces Inclusion of IsoPSA® in National Comprehensive Cancer Network® Guidelines for Prostate Cancer Early Detection
May 11, 2022
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics Announces Publication of Real-World Study Demonstrating the Clinical Utility of IsoPSA® for Prostate Cancer Risk Assessment
February 23, 2022
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics Receives Support from JobsOhio
November 08, 2021
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics Presents New Data Supporting the Clinical Validation and Clinical Utility of IsoPSA at the 2021 Annual Meeting of American Urological Association
September 14, 2021
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Cleveland Diagnostics Receives College of American Pathologists (CAP) Accreditation for Its Clinical Laboratory
May 05, 2021
From
Cleveland Diagnostics, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.